Movement disorders: Neurodevelopment and neurobehavioural expression T. ArcherR. J. Beninger Abstract 06 October 2006 Pages: XXXIII - XLI
Evaluation of acute antiapoptotic effects of Li+ in neuronal cell cultures M. YesteD. AlviraA. Camins OriginalPaper 17 August 2006 Pages: 405 - 416
Kynurenine in combination with probenecid mitigates the stimulation-induced increase of c-fos immunoreactivity of the rat caudal trigeminal nucleus in an experimental migraine model E. Knyihár-CsillikJ. ToldiL. Vécsei Short Communication 10 August 2006 Pages: 417 - 421
Association study of polymorphisms in post-synaptic density protein 95 (PSD-95) with schizophrenia S.-J. TsaiC.-J. HongY.-J. Liou OriginalPaper 10 November 2006 Pages: 423 - 426
Cocaine, but not amphetamine, short term treatment elevates the density of rat brain vesicular monoamine transporter 2 K. SchwartzR. NachmanM. Rehavi Short Communication 08 August 2006 Pages: 427 - 430
Levels of neurotrophic factors in the hippocampus and amygdala correlate with anxiety- and fear-related behaviour in C57BL6 mice B. K. YeeS.-W. ZhuJ. Feldon OriginalPaper 08 August 2006 Pages: 431 - 444
Homocysteine levels in aqueous humor and plasma of patients with primary open-angle glaucoma J. B. RoedlS. BleichA. G. M. Jünemann OriginalPaper 24 August 2006 Pages: 445 - 450
Spatial patterns of the pathological changes in neuronal intermediate filament inclusion disease (NIFID): an α-internexin immunohistochemical study R. A. ArmstrongN. J. Cairns OriginalPaper 17 November 2006 Pages: 451 - 456
Blue light improves cognitive performance S. LehrlK. GerstmeyerS. Bleich Rapid communication 25 January 2007 Pages: 457 - 460
Interaction between TPH1 and GNB3 genotypes and electroconvulsive therapy in major depression S. AnttilaK. HuuhkaT. Lehtimäki OriginalPaper 27 October 2006 Pages: 461 - 468
The GNB3 C825T polymorphism and depression among subjects with alcohol dependence A. P. PrestesF. Z. C. MarquesC. H. D. Bau OriginalPaper 08 August 2006 Pages: 469 - 472
Elevated urinary ADAM12 protein levels in lithium-treated bipolar patients C. NadriY. BersudskyG. Agam OriginalPaper 27 October 2006 Pages: 473 - 477
Peripheral serotonergic markers in acutely suicidal patients. 1. Comparison of serotonergic platelet measures between suicidal individuals, nonsuicidal patients with major depression and healthy subjects J. RoggenbachB. Müller-OerlinghausenB. Ahrens OriginalPaper 21 September 2006 Pages: 479 - 487
Structural brain abnormalities in early onset first-episode psychosis A. K. PagsbergW. F. C. BaaréR. P. Hemmingsen OriginalPaper 06 October 2006 Pages: 489 - 498
CSF cholecystokinin, γ-aminobutyric acid and neuropeptide Y in pathological gamblers and healthy controls C. NordinI. Sjödin OriginalPaper 17 November 2006 Pages: 499 - 503
Forty-two-years later: the outcome of childhood-onset schizophrenia H. RemschmidtM. MartinE. Schulz OriginalPaper 10 August 2006 Pages: 505 - 512
Family-based association study of serotonergic candidate genes and attention-deficit/hyperactivity disorder in a German sample P. HeiserA. DempfleJ. Hebebrand OriginalPaper 10 November 2006 Pages: 513 - 521
No evidence for preferential transmission of common valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor gene (BDNF) in ADHD B. G. SchimmelmannS. FriedelJ. Hebebrand OriginalPaper 15 January 2007 Pages: 523 - 526